Filing search / Incannex Healthcare Limited / "Incentive"

PRE 14A

IXHL Incannex Healthcare Limited

31 Oct 24

Preliminary proxy

4:10pm

Incentive Plan (the “2023 Plan”). The compensation committee is responsible for the determination of the compensation of our chief executive officer … -Equity Incentive Plan Compensation All Other Compensation Total Joel Latham (2) Lekhram Changoer Joseph Swan (3) Luigi M. Barbato, M.D. (4

8-K

IXHL Incannex Healthcare Limited

24 Oct 24

Departure of Directors or Certain Officers

7:01am

Medical Officer. The Employment Agreement provides that Dr. Barbato will receive an annual base salary of $375,000, a target annual incentive of up to 20 … % of base salary, long-term incentive plan and employee benefit plan participation, and the reimbursement of business expenses. Dr. Barbato was granted

8-K

EX-10.1

IXHL Incannex Healthcare Limited

24 Oct 24

Departure of Directors or Certain Officers

7:01am

(but not downward) at the Company’s discretion. (b) Short-Term Incentive Bonus. Employee shall be eligible to receive a short-term incentive bonus … (the “Incentive Bonus”), with the target amount of Incentive Bonus equal to twenty percent (20%) of Employee’s Base Salary in the year to which the Incentive Bonus

8-K

IXHL Incannex Healthcare Limited

15 Oct 24

Entry into a Material Definitive Agreement

3:54pm

with the end of the Australian financial year. The Research and Development Tax Incentive (“RDTI”) program is a key program under the Australian government's

8-K

EX-10.1

IXHL Incannex Healthcare Limited

15 Oct 24

Entry into a Material Definitive Agreement

3:54pm

accrued but not yet been received by the Borrower, in the relevant Financial Year, including providing a draft copy of the R&D Tax Incentive Schedule … ; and (d) any other information required by the Financier to be included in the letter. R&D Tax Incentive Program means the “research and development

8-K

EX-99.1

rmylb4 8y9jc

30 Sep 24

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates

4:01pm

10-K

EX-4.2

es5zfr483e5

30 Sep 24

Annual report

7:30am

10-K

EX-97.1

u8loeq dvl3djo6h

30 Sep 24

Annual report

7:30am

10-K

EX-10.9

h4kox4wfs2d6ghmox2r2

30 Sep 24

Annual report

7:30am

10-K

jhh286p

30 Sep 24

Annual report

7:30am

8-K

EX-10.1

kxi5ifwo7map9

10 Sep 24

Entry into a Material Definitive Agreement

7:30am

8-K

EX-10.2

i6d4 submab7l9t

10 Sep 24

Entry into a Material Definitive Agreement

7:30am

S-1/A

9nvuzu6 do9i9

17 Jul 24

IPO registration (amended)

8:47am

S-1

466tgh1x9i im9rsjh

3 Jul 24

IPO registration

6:29am

8-K

EX-10.1

wk3hli56xi6hmyct

5 Mar 24

Departure of Directors or Certain Officers

6:11am

10-Q

nnjapqpfah66

14 Feb 24

Quarterly report

6:16am

10-Q

EX-10.14

4wx zsedkabin

14 Feb 24

Quarterly report

6:16am

S-8

EX-5.1

bbtjhytfmgnlmcpjt

20 Dec 23

Registration of securities for employees

5:05pm

S-8

up2peijg9fa50mxd

20 Dec 23

Registration of securities for employees

5:05pm